The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the ...

The US federal government has named the next 15 medicines that will be subject to Medicare pricing negotiation and reductions due to come into effect at the start of 2028. The list has been announced ...

Better insulation and ventilation in social housing mean thousands of children no longer need medication for asthma or allergies. This is the conclusion of a large-scale study involving 2 million ...

The Trump administration has expanded its TrumpRx drug pricing platform to 54 medications, adding 11 drugs since its February launch, as questions persist about the site’s overall impact on ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused disruptions for physicians and health consequences for families nationwide, ...

(The Hill) — The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 ...

The federal direct-to-consumer website TrumpRx.gov currently lists 54 brand-name medications accessible through manufacturer-run cash discount programs. That number is expected to grow, as the White ...

Innoviva, Inc. engages in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine ...

Premiums have more than doubled for millions of Americans since enhanced Affordable Care Act tax credits expired, and millions more are projected to lose coverage over the next decade. The ...